Facehun
Résultats de Recherche
Voir tous les résulats
  • Nous rejoindre
    Identifiant
    S’inscrire
    Mode nuit

Rechercher

Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis

  • Fil d’actualités
  • EXPLORER
  • Pages
  • Groupes
  • Evènements
  • regarder
  • Blogs
  • Marketplace
  • Offres
  • Emplois
  • Articles
  • Posts
  • Utilisateurs
  • Pages
  • Groupes
  • Evènements
  • Isha Singh Ajout d’un nouvel article Otthon
    2025-09-26 13:12:29 -
    A New Axis in Autoimmune Care: The Baricitinib Market Landscape Industry Trends and Forecast to 2029
    The baricitinib market is expected to witness market growth at a rate of 11.90% in the forecast period of 2022 to 2029. Baricitinib, a small-molecule Janus kinase (JAK) inhibitor sold most widely under the brand name Olumiant (Eli Lilly/Incyte), has evolved from a rheumatoid-arthritis therapy into a multi-indication platform with growing commercial footprint. Beyond its original approval for...
    0 Commentaires 0 Parts 6325 Vue
    Connectez-vous pour aimer, partager et commenter!
  • Medipharm Solutions Ajout d’un nouvel article Egészség
    2026-03-21 10:27:29 -
    A Practical Guide to Aggregate Reporting in Pharmacovigilance
    If you've been around drug safety for even a short time, you've probably heard the term aggregate reporting in pharmacovigilance . At first, it sounds technical and maybe a bit dry. But the truth is, it sits right at the heart of how medicines stay safe after they reach real people. Let's be honest. Individual case reports matter, but they only tell part of the story. Aggregate reports? They...
    0 Commentaires 0 Parts 681 Vue
    Connectez-vous pour aimer, partager et commenter!
  • Sophie Lane Ajout d’un nouvel article Otthon
    2026-03-05 15:34:16 -
    Drug Safety Solutions & Pharmacovigilance Industry: Enhancing Patient Safety in a High-Volume Market
    The pharmaceutical landscape is currently undergoing a significant shift toward automated and AI-driven safety monitoring to manage the increasing volume of adverse event reports. The Drug Safety Solutions & Pharmacovigilance Market was valued at USD 13,242.32 billion in 2024 and is projected to reach USD 23,442.20 billion by 2032, expanding at a CAGR of...
    0 Commentaires 0 Parts 484 Vue
    Connectez-vous pour aimer, partager et commenter!
  • Vanshika Swami Ajout d’un nouvel article Egészség
    2026-03-11 14:54:44 -
    Global Pharmacovigilance Market Outlook and Key Growth Drivers to 2031
    The global pharmacovigilance market is set to experience substantial growth over the coming decade as the pharmaceutical industry intensifies efforts to ensure drug safety, regulatory compliance, and effective post-marketing surveillance. Pharmacovigilance encompasses the science and activities related to detecting, assessing, understanding, and preventing adverse drug reactions (ADRs) and...
    0 Commentaires 0 Parts 614 Vue
    Connectez-vous pour aimer, partager et commenter!
  • Ganesh Patil Ajout d’un nouvel article Egyéb
    2025-10-09 14:00:41 -
    Meloxicam Market – Meloxicam Market Analysis: Global Size, Share & Future Outlook
    " Meloxicam Market – Global Industry Trends, Growth, Share, Size, and Forecast to 2032 Introduction  Meloxicam — a long-acting nonsteroidal anti-inflammatory drug (NSAID) widely used to manage pain and inflammation in osteoarthritis, rheumatoid arthritis, and other musculoskeletal disorders — remains a key molecule in pain-management portfolios around the world....
    0 Commentaires 0 Parts 4099 Vue
    Connectez-vous pour aimer, partager et commenter!
  • Isha Singh Ajout d’un nouvel article Egyéb
    2025-10-06 13:19:09 -
    Olumiant’s Moment: The Global Baricitinib Market - Current Snapshot and Where It’s Headed
    The baricitinib market is expected to witness market growth at a rate of 11.90% in the forecast period of 2022 to 2029. Data Bridge Market Research report on baricitinib market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. Baricitinib (brand name Olumiant) is an...
    0 Commentaires 0 Parts 3681 Vue
    Connectez-vous pour aimer, partager et commenter!
© 2026 Facehun French
English Magyar Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
Rólunk Felhasználói feltételek Adatvédelem Contactez nous Annuaire